|
|
||||||||
Papers In Press, published online ahead of print June 21, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Physiology Dept., Michigan State University, East Lansing, MI 48824
Corresponding Author: jump{at}msu.edu
Hepatic fatty acid elongases (Elovl-1, -2, -5 and -6) and desaturases (delta5, delta6 and delta9) play an important role in hepatic and whole body lipid composition. This report examines the role key transcription factors play in the control of hepatic elongase and desaturase expression and lipid composition in rat primary hepatocytes and in liver in vivo. Studies with PPARalpha (-/-) null mice establish that PPARalpha is required for WY14643-mediated induction of Elovl-5, Elovl-6 and all 3 desaturases (delta5D, delta6D and delta9D). Nuclear SREBP-1 was increased in hepatocyte nuclei by insulin, the LXR agonist (T1317) or by recombinant adenoviral over expression. Elevated nuclear SREBP-1 correlated with induction of transcripts encoding Elovl-6, delta5D, delta6D and delta9D. Of these, only delta9D is also regulated independently by LXR agonist. Glucose induction of L-pyruvate kinase (L-PK), delta9D and Elovl-6 expression correlated with the accumulation of ChREBP in nuclei of rat primary hepatocytes. Over expression of dominant negative MLX established that the ChREBP/MLX heterodimer was required for glucose induction of these transcripts. Suppression of Elovl-6 and delta9D expression in livers of streptozotocin-induced diabetic rats and high fat-fed glucose intolerant mice correlated with low levels of nuclear SREBP-1. In leptin deficient obese mice (Lepob/ob), elevated SREBP-1 and MLX nuclear content correlated with elevated Elovl-5, Elovl-6 and delta9D expression and massive accumulation of monounsaturated fatty acids (18:1,n-7 & n-9) in hepatic neutral lipids. Diabetes- and obesity-induced changes in hepatic lipid composition correlated with changes in elongase and desaturase expression and elongase enzyme activity. In conclusion, these studies establish a role for PPARalpha, LXR, SREBP-1, ChREBP and MLX in the control of hepatic fatty acid elongase and desaturase expression and hepatic lipid composition.
Revised on June 20, 2006
Accepted on June 20, 2006
Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Igarashi, K. Ma, L. Chang, J. M. Bell, and S. I. Rapoport Rat heart cannot synthesize docosahexaenoic acid from circulating {alpha}-linolenic acid because it lacks elongase-2 J. Lipid Res., August 1, 2008; 49(8): 1735 - 1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, M. Torres-Gonzalez, S. Tripathy, D. Botolin, B. Christian, and D. B. Jump Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition J. Lipid Res., July 1, 2008; 49(7): 1538 - 1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Igarashi, K. Ma, L. Chang, J. M. Bell, and S. I. Rapoport Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain J. Lipid Res., November 1, 2007; 48(11): 2463 - 2470. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |